Skip to main content
EuroGCT
Menu
Close
Help and support
Help and support
FAQ's
Glossary
FAQ's
How is the safety of a new gene therapy determined?
How are gene and cell therapies different to 'traditional' therapies?
Where do embryonic stem cells for research come from?
How is the production of gene and cell therapies different to traditional treatments?
Why do we need gene and cell therapies? How are they different from traditional medicines and treatments?
What is genetic testing?
Is it ethical to use animals in health and scientific research?
What are the roles of regulators in the development of gene and cell therapies?
See all FAQs
Glossary
Accelerated assessment
Adeno-associated virus (AAV)
Adenovirus
Adult stem cells
Advanced Therapy Investigational Medicinal Product (ATIMP)
Advanced Therapy Medicinal Product (ATMP)
Advertising
Antibody
See full Glossary
Search
Select language
Select language
English
Français
Deutsch
Italiano
Polski
Español
Português
Select language
Select language
English
Français
Deutsch
Italiano
Polski
Español
Português
Condition
Blood disorders
Sickle Cell Disease
Cardiovascular Disease
Heart Disease
Stroke
Bowel Disease
Cancer
Cystic Fibrosis
Eye Disease
Immune Conditions
Diabetes
Multiple Sclerosis
Kidney Disease
Liver Disease
Lung Disease
Bone and Muscle Conditions
Muscular Dystrophy
Spinal Cord Injuries
Neurological Disorders
Alzheimer's Disease
Cerebral Palsy
Huntington's Disease
Motor Neurone Disease
Parkinson's Disease
Spinal Muscular Atrophy
Skin
Epidermolysis Bullosa
Reproduction and Fertility
Theme
Cell and Gene Fundamentals
Blood Stem Cells
Cord Blood
Embryonic Stem Cells
iPS cells
MSCs
Skin Stem Cells
Current and Potential Uses
Cell Therapy
Gene Therapy
Clinical Trials
CAR-T Therapy
Methods and Tools
Disease Modelling
Organoids
Tissue Engineering
Gene Editing
Reprogramming
Ethics and Society
Patient Involvement
Policy & Regulation
Unproven Treatments
Spotlight on Research
Main navigation
Discover
Discover
Educational Resources Directory
INTENS
LEARN
Research Pathways
Research Pathways
EuroGCT Key Resources
ATMP Engage
CARTALLEU
Actors and Network database
About Us
Contact
Breadcrumb
Home
Methods and Tools
Methods and Tools
Resources & Factsheets
English
EuroGCT Resource
What is tissue engineering?
Related Topics
Disease Modelling
Methods and Tools
Research
Tissue Engineering
EuroGCT Resource
Why are some conditions more suitable for gene and cell therapies than others?
Related Topics
Current and Potential Uses
Cell Therapy
Gene Therapy
Clinical Trials
Methods and Tools
Disease Modelling
Gene Editing
Ethics and Society
Patient Involvement
Policy & Regulation
Research
EuroGCT Resource
Where should I start?
Related Topics
Cell and Gene Fundamentals
Cell Therapy
Clinical Trials
Current and Potential Uses
Ethics and Society
Factsheets
Gene Therapy
Methods and Tools
Patient Involvement
Policy & Regulation
Research
English
EuroGCT Resource
Using 'reprogrammed' cells to model diseases
Related Topics
iPS cells
Current and Potential Uses
Methods and Tools
Disease Modelling
Organoids
Tissue Engineering
Reprogramming
Identifying Genetic Disease
Related Topics
Current and Potential Uses
Ethics and Society
Methods and Tools
ABPI Animals and Medicines Research
Related Topics
Ethics and Society
Methods and Tools
Organoids - from stem cells to future technologies
Related Topics
Clinical Trials
Disease Modelling
Methods and Tools
EuroGCT Resource
Cell Culture
Related Topics
Disease Modelling
Explore Stem Cells
Methods and Tools
Research
EuroGCT Resource
Stem cell futures: An introduction to iPS cells
Related Topics
Current and Potential Uses
Explore Stem Cells
iPS cells
Methods and Tools
Reprogramming
EuroGCT Resource
What is cloning, and what does it have to do with stem cell research?
Related Topics
Current and Potential Uses
Disease Modelling
Methods and Tools
Research
Pagination
Page
1
Page
2
Page
3
Next page
››
Last page
Last »
